Ticker

New capability adds consultative support and strengthens Nephros' broader water safety offering SOUTH ORANGE, NJ, April 1, 2026 PRISM MediaWire (Press Release Service – Press Release Distribution)– Nephros, Inc.

SOUTH ORANGE, N.J., April 01, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced an expansion of its customer-facing, water-safety support capabilities following the ASSE 12080 Legionella Water Safety and Management Specialist Certification earned by Brianne McGuire, Director of Business…

Nephros (NASDAQ: NEPH - Get Free Report) and Envista (NYSE: NVST - Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk. Volatility and Risk Nephros has a beta of 1.42, indicating

Nephros, Inc. (NEPH) Q4 2025 Earnings Call Transcript

Full-Year Net Revenue Increased 33% Y-O-Y to $18.8 Million and Fourth-Quarter Net Revenue up 22% Y-O-Y to $4.7 Million Reports Second Consecutive Year of Positive Net Income SOUTH ORANGE, N.J., March 12, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Nephros, Inc.